Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries

1. YagerP, DomingoGJ, GerdesJ (2008) Point-of-care diagnostics for global health. Annu Rev Biomed Eng 10: 107–144.

2. PeelingRW, MabeyD (2010) Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 16: 1062–1069.

3. PaiNP, KleinMB (2008) Are we ready for home-based, self-testing for HIV? Future HIV Therapy 2: 515–520.

4. US Food and Drug Administration (2012) FDA approves first over-the-counter home-use rapid HIV test. FDA news release, 3 July 2012. Available: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm310542.htm. Accessed 5 August 2012.

5. PalamountainKM, BakerJ, CowanEP, EssajeeS, MazzolaLT, et al. (2012) Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis 205 Suppl 2: S181–S190.

6. UNITAID (2011) UNITAID Annual Report 2011. UNITAID, Geneva. Available: http://www.unitaid.eu/images/Annual_Report_2011/UNITAID_AR2011_EN.pdf. Accessed 5 August 2012.

7. Price CP, St. John A, Hicks JM (2004) Point-of-care testing. 2nd edition. Washington (D.C.): American Association for Clinical Chemistry.

8. EhrmeyerSS, LaessigRH (2007) Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin Chem Lab Med 45: 766–773.

9. PaiNP, PaiM (2012) Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov Med 13: 35–45.

10. PriceCP (2001) Point of care testing. BMJ 322: 1285–1288.

11. BissonnetteL, BergeronMG (2010) Diagnosing infections–current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect 16: 1044–1053.

12. BoehmeCC, NicolMP, NabetaP, MichaelJS, GotuzzoE, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495–1505.

13. The PLoS Medicine Editors (2011) Speed and convenience aren't everything with diagnostics. PLoS Med 8: e1001113 doi:10.1371/journal.pmed.1001113.

14. SquireSB, BelayeAK, KashotiA, SalaniponiFM, MundyCJ, et al. (2005) ‘Lost’ smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 9: 25–31.

15. BassettIV, WangB, ChettyS, MazibukoM, BearnotB, et al. (2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 51: 135–139.

16. Cohen-BacrieS, NinoveL, NougairedeA, CharrelR, RichetH, et al. (2011) Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care. PLoS One 6: e22403 doi:10.1371/journal.pone.0022403.

17. ChartrandC, LeeflangMM, MinionJ, BrewerT, PaiM (2012) Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156: 500–511.

18. PaiNP, BarickR, TulskyJP, ShivkumarPV, CohanD, et al. (2008) Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med 5: e92 doi:10.1371/journal.pmed.0050092.

19. NiemzA, FergusonTM, BoyleDS (2011) Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol 29: 240–250.

20. VassallA, van KampenS, SohnH, MichaelJS, JohnKR, et al. (2011) Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8: e1001120 doi:10.1371/journal.pmed.1001120.

21. PaiM, MinionJ, SteingartK, RamsayA (2010) New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 16: 271–284.

22. ChokoAT, DesmondN, WebbEL, ChavulaK, Napierala-MavedzengeS, et al. (2011) The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med 8: e1001102 doi:10.1371/journal.pmed.1001102.

23. GiftTL, PateMS, HookEW3rd, KasslerWJ (1999) The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 26: 232–240.

24. CobelensF, van den HofS, PaiM, SquireSB, RamsayA, et al. (2012) Which new diagnostics for tuberculosis, and when? J Infect Dis 205 (Suppl 2) S191–S198.

25. SchitoML, PeterTF, CavanaughS, PiatekAS, YoungGJ, et al. (2012) Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis 205 Suppl 2: S169–S180.

26. DeblondeJ, De KokerP, HamersFF, FontaineJ, LuchtersS, et al. (2010) Barriers to HIV testing in Europe: a systematic review. Eur J Public Health 20: 422–432.

27. AsiimweC, KyabayinzeDJ, KyalisiimaZ, NabakoozaJ, BajabaiteM, et al. (2012) Early experiences on the feasibility, acceptability, and use of malaria rapid diagnostic tests at peripheral health centres in Uganda-insights into some barriers and facilitators. Implement Sci 7: 5.

28. HeunisJC, WoutersE, NortonWE, EngelbrechtMC, KigoziNG, et al. (2011) Patient- and delivery-level factors related to acceptance of HIV counseling and testing services among tuberculosis patients in South Africa: a qualitative study with community health workers and program managers. Implement Sci 6: 27.

29. PaiNP, JoshiR, MoodieEE, TaksandeB, KalantriSP, et al. (2009) Profile of adults seeking voluntary HIV testing and counseling in rural Central India: results from a hospital-based study. AIDS Care 21: 294–300.

30. PriceCP (2011) Point-of-care testing. Care closer to home. Point of Care 10: 88–92.

31. MacPhersonP, WebbEL, ChokoAT, DesmondN, ChavulaK, et al. (2011) Stigmatising attitudes among people offered home-based HIV testing and counselling in Blantyre, Malawi: construction and analysis of a stigma scale. PLoS One 6: e26814 doi:10.1371/journal.pone.0026814. doi:10.1371/journal.pone.0026814.

32. BalochNA, PaiM (2012) Tuberculosis control: business models for the private sector. Lancet Infect Dis 12: 579–580.

33. GrenierJ, PintoL, NairD, SteingartK, DowdyD, et al. (2012) Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Respir J 39: 502–505.

34. JarosawlskiS, PaiM (2012) Why are inaccurate tuberculosis serological tests widely used in the Indian private healthcare sector? A root-cause analysis. J Epidemiol Global Health 2: 39–50.

35. X Prize Foundation (2012) Qualcomm Tricorder X PRIZE. Available: http://www.qualcommtricorderxprize.org/.

36. PaiM (2011) Improving TB diagnosis: difference between knowing the path and walking the path. Expert Rev Mol Diagn 11: 241–244.

37. DowdyDW, SteingartKR, PaiM (2011) Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 8: e1001074 doi:10.1371/journal.pmed.1001074.

38. BhargavaA, PintoLM, PaiM (2011) Mismanagement of tuberculosis in India: causes, consequences, and the way forward. Hypothesis 9: 1–13.

39. PaiNP, KleinMB (2009) Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challenges. Womens Health 5: 55–62.

40. EngelN, KennethJ, PaiM (2012) TB diagnostics in India: creating an ecosystem for innovation. Expert Rev Mol Diagn 12: 21–24.

41. DowdyDW, CattamanchiA, SteingartKR, PaiM (2011) Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med 8: e1001063 doi:10.1371/journal.pmed.1001063.

42. Pant PaiN, JoshiR, DograS, TaksandeB, KalantriSP, et al. (2007) Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS One 2: e367 doi:10.1371/journal.pone.0000367. doi:10.1371/journal.pone.0000367.

43. PaiNP, BalramB, ShivkumarS, Martinez-CajasJL, ClaessensC, et al. (2012) Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis 12: 373–380.

44. SchnippelK, Meyer-RathG, LongL, MacleodW, SanneI, et al. (2012) Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop Med Int Health Epub ahead of print. doi:10.1111/j.1365-3156.2012.03028.x.